VIRACTA THERAPEUTICS, INC.

Analyst Reco. Viracta Therapeutics, Inc.

Equities

VIRX

US92765F1084

Market Closed - Nasdaq Other stock markets 15:53:31 2024-04-29 EDT			5-day change	1st Jan Change
0.821 ^USD	-0.88%		-6.70%	+44.04%

04-15	Viracta Therapeutics, Inc. Reports Positive Topline Results from Stage 1 of the Pivotal Phase 2 NAVAL-1 Trial	CI
04-01	Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Cuts Price Target on Viracta Therapeutics to $6 From $7, Keeps Outperform, Speculative Risk	11-10	MT
HC Wainwright Lowers Price Target on Viracta Therapeutics to $10 From $33, Maintains Buy Rating	23-07-05	MT
RBC Cuts Price Target on Viracta Therapeutics to $7 From $8, Maintains Outperform, Speculative Risk Rating	23-05-09	MT
Oppenheimer Adjusts Viracta Therapeutics Price Target to $16 From $14, Maintains Outperform Rating	23-03-27	MT
RBC Cuts Price Target on Viracta Therapeutics to $8 From $10, Maintains Outperform, Speculative Risk	22-11-11	MT
History shows stocks can weather rate hike cycle	22-03-16	RE
Viracta Therapeutics Initiated at Outperform by RBC With Speculative Risk Qualifier, Price Target Started at $10/Share	22-02-01	MT
Viracta Says Epstein-Barr Therapy Had 40% Overall Response Rate in Trial; Shares Fall	21-12-13	MT
VIRACTA THERAPEUTICS : HC Wainwright Starts Viracta Therapeutics at Buy With $35 Price Target	21-05-03	MT
VIRACTA THERAPEUTICS : SVB Leerink Initiates Viracta Therapeutics at Outperform With $18 Price Target	21-04-26	MT
VIRACTA THERAPEUTICS : Evercore ISI Starts Viracta Therapeutics at Outperform with $45 Price Target	21-03-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer